Study of ENMD-2076 in Patients With Advanced/Metastatic Soft Tissue Sarcoma
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
This is a phase 2 study of ENMD-2076 in patients with advanced/metastatic soft tissue
sarcoma. This study will help to understand how well ENMD-2076 works and how safe and
tolerable the drug is in this patient population.